Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
- Published in:
- Medical Oncology, 2014, v. 31, n. 2, p. 1, doi. 10.1007/s12032-013-0828-9
- By:
- Publication type:
- Article